Concepedia
Statistics
Publications
10
Citations
1.3K
H-Index
Active since
2013
Affiliations
Pfizer (United States)(Current)
Sanford Burnham Prebys Medical Discovery Institute
Discovery Institute
Pfizer (United Kingdom)
Inserm
Ryan M. Esquejo is an author at Pfizer (United States) specializing in medicine, pharmacology, and metabolism.
Top concepts
MedicinePharmacologyDiabetesAutophagyMetabolismBiochemistryCell BiologyCell SignalingPharmacotherapyMetabolic Syndrome
Publications per year
2013–2022
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Ji Miao, Alisha V. Ling, Praveen V. Manthena et al. · Nature Communications · 2015 · 360 citations · Full text
Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice
Emily Cokorinos, Jake Delmore, Allan R. Reyes et al. · Cell Metabolism · 2017 · 259 citations · Full text
Metabolic Syndrome, Muscle Physiology, Muscle Function +15
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
Danna M. Breen, Hanna Kim, Donald Bennett et al. · Cell Metabolism · 2020 · 168 citations
Oncology, Weight Loss, Chemoprevention Strategy +10
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
Ryan M. Esquejo, Christopher T. Salatto, Jake Delmore et al. · EBioMedicine · 2018 · 146 citations · Full text
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Aditi R. Saxena, Donal Gorman, Ryan M. Esquejo et al. · Nature Medicine · 2021 · 134 citations
Metabolic Syndrome, Diabetes Management, Diabetes +5
1–5 of 10